Ajinomoto x Matrixome


Matrixome provides research and clinical grade laminin E8 fragments that are globally utilized for manufacture of clinical stem cell banks and transplantable tissue. Our unique technology provides numerous advantages over other ECMs and full-length laminin.

Ajinomoto is a global supplier of advanced clinical grade/GMP human pluripotent stem cells (hiPSCs/ESCs) and MSC culture media, as well as growth factors. Originating as a pioneering co-development with CiRA, our StemFit brand of media now supports research and further manufacturing around the world.

Used together, Ajinomoto’s StemFit media and Matrixome’s iMatrix ECMs deliver unrivaled culture performance in a fully chemically defined and animal-origin-free environment.